Log in to save to my catalogue

The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the contin...

The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the contin...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5266482

The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2

About this item

Full title

The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2

Publisher

United States: Elsevier Inc

Journal title

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2017, Vol.6 (1), p.50-59

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Abstract Introduction Among other metabolic functions, the apolipoprotein E (APOE) plays a crucial role in neuroinflammation. We aimed at assessing whether APOE ε4 modulates levels of glial cerebrospinal fluid (CSF) biomarkers and their structural cerebral correlates along the continuum of Alzheimer's disease (AD). Methods Brain magnetic resonance...

Alternative Titles

Full title

The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5266482

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5266482

Other Identifiers

ISSN

2352-8729

E-ISSN

2352-8729

DOI

10.1016/j.dadm.2016.12.002

How to access this item